APA

Myers R. M., Greiner S. M., Harvey M. E., Griesmann G., Kuffel M. J., Buhrow S. A., Reid J. M., Federspiel M., Ames M. M., Dingli D., Schweikart K., Welch A., Dispenzieri A., Peng K. & Russell S. J. (20071206). Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. : Clinical pharmacology and therapeutics.

Chicago

Myers R M, Greiner S M, Harvey M E, Griesmann G, Kuffel M J, Buhrow S A, Reid J M, Federspiel M, Ames M M, Dingli D, Schweikart K, Welch A, Dispenzieri A, Peng K-W and Russell S J. 20071206. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. : Clinical pharmacology and therapeutics.

Harvard

Myers R. M., Greiner S. M., Harvey M. E., Griesmann G., Kuffel M. J., Buhrow S. A., Reid J. M., Federspiel M., Ames M. M., Dingli D., Schweikart K., Welch A., Dispenzieri A., Peng K. and Russell S. J. (20071206). Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. : Clinical pharmacology and therapeutics.

MLA

Myers R M, Greiner S M, Harvey M E, Griesmann G, Kuffel M J, Buhrow S A, Reid J M, Federspiel M, Ames M M, Dingli D, Schweikart K, Welch A, Dispenzieri A, Peng K-W and Russell S J. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. : Clinical pharmacology and therapeutics. 20071206.